Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12928744 | 0.98 | EPHX1 (0.37) | EPHX1CYP19A1NAAASMN1; SMN2HTT | |
| SCHEMBL8283633 | 0.78 | EPHX1 (0.36) | EPHX1CYP19A1NAAASMN1; SMN2HTT | |
| SCHEMBL10352166 | 0.74 | MEN1 (0.35) | — | |
| SCHEMBL26077300 | 0.72 | CYP4F2 (0.41) | EPHX1CYP19A1NAAA | |
| SCHEMBL14960420 | 0.71 | TSHR (0.35) | — | |
| SCHEMBL24781028 | 0.71 | EPHX1 (0.42) | EPHX1CYP19A1NAAASMN1; SMN2HTT | |
| SCHEMBL10578670 | 0.71 | CYP19A1 (0.31) | EPHX1CYP19A1 | |
| SCHEMBL20526369 | 0.70 | CA12 (0.32) | EPHX1CYP19A1 | |
| SCHEMBL1357594 | 0.70 | ACHE (0.32) | EPHX1CYP19A1 | |
| SCHEMBL1357595 | 0.70 | CA12 (0.32) | EPHX1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023083295-A1 | ESTER DERIVATIVES OF N4-HYDROXYCYTIDINE AND USE THEREOF | SUZHOU SPRING-SEA BIO-PHARMACEUTICALS CO., LTD. (CN) | 2023-05-19 | — | — | WO | disclosed |